Exhibit 7.01
JOINT FILING AGREEMENT
THIS JOINT FILING AGREEMENT is entered into as of February 22, 2016, by and among the parties hereto. The undersigned hereby agree that the Statement on Schedule 13D with respect to the common stock, par value $0.001 per share, of SciClone Pharmaceuticals, Inc. and any amendment thereto signed by each of the undersigned shall be filed on behalf of each undersigned pursuant to and in accordance with the provisions of Rule 13d-1(k)(1) under the Securities Exchange Act of 1934, as amended.
Ally Bridge LB Healthcare Master Fund Limited | ||
| By: | /s/ Bin Li | |
Name: Bin Li Title: Director | ||
Ally Bridge LB Management Limited | ||
| By: | /s/ Bin Li | |
Name: Bin Li Title: Director | ||
ABG Management Limited | ||
| By: | /s/ Fan Yu | |
Name: Fan Yu Title: Director | ||
| Fan Yu | ||
| By: | /s/ Fan Yu | |
| Bin Li | ||
| By; | /s/ Bin Li | |
